Sorrento Therapeutics, Inc.
CIK 850261 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 15, 2022 · Latest: Nov. 15, 2022
On this page
- Biography Career background and public profile, where available.
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 3 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
3 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 5, 2023 | CELU | S | 6,307,158 | — | — | 5,050,427 Direct | -55.53% | Disposed | (price as of 2026-08-21) |
| Sept. 29, 2023 | CELU | S | 9,064,539 | — | — | 11,357,585 Direct | -44.39% | Disposed | (price as of 2026-08-21) |
| Sept. 21, 2023 | SCLXW | S | 4,490,617 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Sept. 21, 2023 | SCLXW | S | 60,068,585 | — | — | 1,917,210 Direct | -96.91% | Disposed | (price as of 2026-08-21) |
| Dec. 2, 2022 | SCLXW | P | 224,841 | $0.35 | $78,694 | 4,490,617 Direct | +5.27% | Acquired | -54.4% (price as of 2026-08-21) |
| Nov. 25, 2022 | SCLXW | P | 46,172 | $0.44 | $20,316 | 4,265,776 Direct | +1.09% | Acquired | -63.7% (price as of 2026-08-21) |
| Nov. 23, 2022 | SCLXW | P | 442,829 | $0.40 | $177,132 | 4,219,604 Direct | +11.73% | Acquired | -60.1% (price as of 2026-08-21) |
| Nov. 22, 2022 | SCLXW | P | 672,775 | $0.23 | $154,738 | 3,776,775 Direct | +21.67% | Acquired | -30.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 21, 2023 | SCLXW | Warrants to Purchase Common Stock | Common Stock (4,490,617) | $11.50 | Nov. 10, 2027 | 4,490,617 | Disposed |
| Dec. 2, 2022 | SCLXW | Warrants to Purchase Common Stock | Common Stock (224,841) | $11.50 | Nov. 10, 2027 | 224,841 | Acquired |
| Nov. 25, 2022 | SCLXW | Warrants to Purchase Common Stock | Common Stock (46,172) | $11.50 | Nov. 10, 2027 | 46,172 | Acquired |
| Nov. 23, 2022 | SCLXW | Warrants to Purchase Common Stock | Common Stock (442,829) | $11.50 | Nov. 10, 2027 | 442,829 | Acquired |
| Nov. 22, 2022 | SCLXW | Warrants to Purchase Common Stock | Common Stock (672,775) | $11.50 | Nov. 10, 2027 | 672,775 | Acquired |
| Nov. 10, 2022 | SCLXW | Warrant to Purchase Common Stock | Common Stock (307,296) | $11.50 | Nov. 10, 2027 | 307,296 | Acquired |
| Nov. 10, 2022 | SCLXW | Warrant to Purchase Common Stock | Common Stock (2,796,704) | $11.50 | Nov. 10, 2027 | 2,796,704 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.